Ajay Bhalla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ajay Bhalla has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Abdel Douiri
King’s College London
1 shared publication - Charles David Alexander Wolfe
King’s College London
1 shared publication - Iain James Marshall
King’s College London
1 shared publication - Majed Sameer Obaid
Department of Community Medicine and Pilgrims Health Care, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
1 shared publication Martin James
Royal Devon University Healthcare NHS Foundation Trust, EX2 5DW Exeter, UK
1 shared publication- Matthew D. L. O’cOnnell
School of Population Health & Environmental Sciences, King's College London, London, UK matthew.o'
1 shared publication
Latest Publications
- Open Access
- 27 February 2026
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 485, 125765
Stroke preventive strategies and long-term cognitive function: A population-based study
- 27 February 2026
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 485, 125765
Open AccessStroke preventive strategies and long-term cognitive function: A population-based study
- Open Access
- 20 January 2026
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 87 (1) , 50187
The Changing Landscape for Hyper-Acute Ischaemic Stroke Care
Delivery of reperfusion therapies such as thrombolysis and mechanical thrombectomy have revolutionised the treatment for acute ischaemic stroke with reduction in disability and mortality. Extended time windows for thrombolysis for patients presenting beyond 4.5 hours including wake up stroke have now increased the eligibility for these treatments. Tenecteplase has emerged as alternative thrombolytic agent to alteplase, with practical advantages. Mechanical thrombectomy is now available to a wider group of patients than previously considered such as patients presenting beyond 6 hours up to 24 hours, those with large core anterior circulation infarcts and posterior circulation stroke. Advances in brain imaging and their application to determine salvageable brain tissue is crucial in delivery of these interventions. Systems of care to enhance the delivery of these time critical treatments such as pre-hospital video triage and mobile stroke units may play a vital role in maximising population benefits from high-quality hyper-acute stroke care. The purpose of this review is to highlight the expansion of evidence for acute therapeutic interventions for ischaemic stroke and technologies to facilitate their delivery.
- 20 January 2026
- Published by IMR Press in British Journal of Hospital Medicine
- Vol. 87 (1) , 50187
Open AccessThe Changing Landscape for Hyper-Acute Ischaemic Stroke Care
Delivery of reperfusion therapies such as thrombolysis and mechanical thrombectomy have revolutionised the treatment for acute ischaemic stroke with reduction in disability and mortality. Extended time windows for thrombolysis for patients presenting beyond 4.5 hours including wake up stroke have now increased the eligibility for these treatments. Tenecteplase has emerged as alternative thrombolytic agent to alteplase, with practical advantages. Mechanical thrombectomy is now available to a wider group of patients than previously considered such as patients presenting beyond 6 hours up to 24 hours, those with large core anterior circulation infarcts and posterior circulation stroke. Advances in brain imaging and their application to determine salvageable brain tissue is crucial in delivery of these interventions. Systems of care to enhance the delivery of these time critical treatments such as pre-hospital video triage and mobile stroke units may play a vital role in maximising population benefits from high-quality hyper-acute stroke care. The purpose of this review is to highlight the expansion of evidence for acute therapeutic interventions for ischaemic stroke and technologies to facilitate their delivery.